Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
praluent
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
regeneron pharmaceuticals
amgen
cholesterol
fda
inclisiran
medco
medicines co.
pcsk9
purdue pharma
rejection
repatha
sanofi
What
bio
healthcare
roundup
cholesterol
abbvie’s
america
american
barbecuing
based
best
biogen
camping
cardiologist
center
check
conference
continue
continues
convoluted
crash
day
debate
democrats
dreams
drug
drugs
expensive
faces
financial
flop
foe
head
headaches
hint
hit
holding
industry
inhibitors
insurance
ipo
Language
unset
Current search:
praluent
×
biotech
×
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More